Designing Drugs At The Level Of Electrons
Henry van den Bedem, PhD
Designing Drugs at the Level of Electrons
We’re entering a new era for small-molecule drug discovery — where AI can generatively design compounds for virtually any protein. By modeling chemistry at the level of electrons and training on an unprecedented proteome-wide dataset, Expedition’s platform enables a new way to create covalent drugs. In this video, I explain how electronic-level insight, generative AI, and experimental data purpose built for AI learning at scale come together to redefine what’s possible in small-molecule design.